Loading stock data…
$35.32-1.13 (-3.10%)
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally.
Omnicell, Inc. in the Healthcare sector is trading at $35.32 with a market capitalization of $1.6B. Wall Street consensus targets $57.86 (7 analysts), implying a +63.8% move over the next 12 months. The stock is currently 36% below its 52-week high of $55.00, remaining 11.1% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $312.21M↑ | $309.88M↓ | $313.98M↑ | $310.63M↑ | $290.56M |
| Gross Profit | $152.94M↑ | $140.36M↑ | $130.32M↓ | $134.50M↑ | $127.68M |
| Operating Income | $32.45M↑ | $16.85M↑ | $415,000↓ | $8.24M↑ | $8.12M |
| Net Income | $24.29M↑ | $11.36M↑ | -$2.03M↓ | $5.46M↓ | $5.64M |
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the heal...